Skip to content

Press

Portfolio-Media Coverage
Gene Editing Therapies Delivered In Vivo: Ensoma’s Emile Nuwaysir on The Long Run
April 24, 2023 Apr 24, 2023 The Timmerman Report
Portfolio-Press Releases
Recode Therapeutics Appoints John G. Matthews, MBBS, MRCP, Ph.D., as Senior Vice President, Clinical Development
April 17, 2023 Apr 17, 2023
Portfolio-Media Coverage
Nido Biosciences divulges new SARMs
February 10, 2023 Feb 10, 2023 Bioworld
Portfolio-Press Releases
Ensoma Announces Closing of Twelve Bio Acquisition
February 9, 2023 Feb 9, 2023
Portfolio-Media Coverage
Ensoma Raises $85M in Series B Funding; Acquires Twelve Bio
January 10, 2023 Jan 10, 2023 FinSMEs
Portfolio-Media Coverage
Ensoma announces financing and acquisition
January 9, 2023 Jan 9, 2023 The Pharma Letter
Portfolio-Media Coverage
Ensoma buys a startup to advance ‘in vivo’ cell therapy work
January 6, 2023 Jan 6, 2023 Biopharma Dive
Portfolio-Media Coverage
Ensoma acquiring Twelve Bio
January 6, 2023 Jan 6, 2023 Labiotech
Portfolio-Media Coverage
On in vivo cell therapy quest, Takeda-backed Ensoma buys a CRISPR upstart and bags $85M
January 5, 2023 Jan 5, 2023 Endpoints
Portfolio-Media Coverage
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
January 5, 2023 Jan 5, 2023 Bloomberg